Page last updated: 2024-12-06

5-amino-1h-tetrazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID20467
CHEMBL ID4469714
MeSH IDM0041807

Synonyms (59)

Synonym
5378-49-4
1h-tetrazole, 5-amino-
5-aminotetrazole
5-amino-1,3,4-tetrazole
nsc3004
aminotetrazole
nsc-3004
5-amino-1h-tetrazole
4418-61-5
1h-tetrazol-5-amine
EU-0000391
5-aminotetrazole, 97%
einecs 224-581-7
nsc 3004
5-amino-1,2,3,4-tetrazole
tetrazol-5-ylamine
ai3-23021
A0427
AKOS000291380
2h-tetrazol-5-amine
STL163513
BBL012169
unii-28jr5ld42t
28jr5ld42t ,
5-amino tetrazole
AM90362
FT-0620027
1h-1,2,3,4-tetrazol-5-amine
DTXSID7052103
5-amino-1h tetrazole
1h-tetrazol-5-ylamine
1h-tetrazole-5-amine
5-amino-1h-tetrazol
amino tetrazole
5-amino-tetrazole
5amino-1h-tetrazole
5 -aminotetrazole
5-amino-1 h-tetrazole
2h-tetrazol-5-ylamine
5-amino-1, 2,3,4-tetrazole
W-106210
Q-200529
5-amino-2h-tetrazole
tetrazole, 5-amino-
5-tetrazolamine
Z1250100717
2-tetrazolium-5-aminide
CHEMBL4469714
1h-1,2,3,4-tetraazol-5-amine
tetrazolium-5-aminide
iminotetrazoline
BCP21869
1h-5aminotetrazole
Q25323820
mfcd00005248
AT27119
EN300-33999
thiolite hat 1
1,2,3,4-tetrazole, 5-amino-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID1889440Anti-virulence activity against Candida albicans SC5314 assessed as inhibition of fungal filamentation by measuring reduction in hyphae formation in Spider medium at 5 uM incubated for 3 to 5 days by stereomicroscopic analysis2022European journal of medicinal chemistry, Feb-15, Volume: 230Unraveling the anti-virulence potential and antifungal efficacy of 5-aminotetrazoles using the zebrafish model of disseminated candidiasis.
AID1608325Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay2019European journal of medicinal chemistry, Oct-01, Volume: 179Synthesis of quinones with highlighted biological applications: A critical update on the strategies towards bioactive compounds with emphasis on lapachones.
AID1889443Anti-virulence activity against Candida albicans SC5314 assessed as inhibition of fungal filamentation by measuring reduction in hyphae formation in YPS plus uridine medium at 5 uM incubated for 3 to 5 days by stereomicroscopic analysis2022European journal of medicinal chemistry, Feb-15, Volume: 230Unraveling the anti-virulence potential and antifungal efficacy of 5-aminotetrazoles using the zebrafish model of disseminated candidiasis.
AID1889409Anti-virulence activity against Candida albicans SC5314 assessed as inhibition of fungal filamentation by measuring reduction in hyphae formation in GlcNAc medium at 5 uM incubated for 3 to 5 days by stereomicroscopic analysis2022European journal of medicinal chemistry, Feb-15, Volume: 230Unraveling the anti-virulence potential and antifungal efficacy of 5-aminotetrazoles using the zebrafish model of disseminated candidiasis.
AID1889401Antifungal activity against Candida albicans SC5314 assessed as inhibition of fungal growth incubated for 24 hrs by broth microdilution assay2022European journal of medicinal chemistry, Feb-15, Volume: 230Unraveling the anti-virulence potential and antifungal efficacy of 5-aminotetrazoles using the zebrafish model of disseminated candidiasis.
AID1889403Toxicity in zebrafish embryos assessed as toxic responses at 200 uM treated at 6 hpf and measured at 120 hpf by stereomicroscopic analysis2022European journal of medicinal chemistry, Feb-15, Volume: 230Unraveling the anti-virulence potential and antifungal efficacy of 5-aminotetrazoles using the zebrafish model of disseminated candidiasis.
AID1889405Toxicity in zebrafish embryos assessed as mortality treated at 6 hpf and measured at 120 hpf by stereomicroscopic analysis2022European journal of medicinal chemistry, Feb-15, Volume: 230Unraveling the anti-virulence potential and antifungal efficacy of 5-aminotetrazoles using the zebrafish model of disseminated candidiasis.
AID1889418Anti-virulence activity against 53-75 RFP expressing cells of Candida albicans M137 in hind brain of zebra fish embryo disseminated candidiasis model assessed as inhibition of fungal filamentation by measuring reduction of hyphae formation in the hind bra2022European journal of medicinal chemistry, Feb-15, Volume: 230Unraveling the anti-virulence potential and antifungal efficacy of 5-aminotetrazoles using the zebrafish model of disseminated candidiasis.
AID1889442Anti-virulence activity against Candida albicans SC5314 assessed as inhibition of fungal filamentation by measuring reduction in hyphae formation in YPS medium at 5 uM incubated for 3 to 5 days by stereomicroscopic analysis2022European journal of medicinal chemistry, Feb-15, Volume: 230Unraveling the anti-virulence potential and antifungal efficacy of 5-aminotetrazoles using the zebrafish model of disseminated candidiasis.
AID1889441Anti-virulence activity against Candida albicans SC5314 assessed as inhibition of fungal filamentation by measuring reduction in hyphae formation in Lee medium at 5 uM incubated for 3 to 5 days by stereomicroscopic analysis2022European journal of medicinal chemistry, Feb-15, Volume: 230Unraveling the anti-virulence potential and antifungal efficacy of 5-aminotetrazoles using the zebrafish model of disseminated candidiasis.
AID1608329Cytotoxicity against human LO2 cells assessed as reduction in cell viability after 48 hrs by MTT assay2019European journal of medicinal chemistry, Oct-01, Volume: 179Synthesis of quinones with highlighted biological applications: A critical update on the strategies towards bioactive compounds with emphasis on lapachones.
AID1889438Toxicity against zebrafish embryo infected with 53-75 RFP expressing cells of Candida albicans M137 assessed as mortality at 2.5 to 10 uM treated at 1 hr post-infection and measured on day 4 post-infection2022European journal of medicinal chemistry, Feb-15, Volume: 230Unraveling the anti-virulence potential and antifungal efficacy of 5-aminotetrazoles using the zebrafish model of disseminated candidiasis.
AID1889408Anti-virulence activity against Candida albicans SC5314 assessed as inhibition of fungal filamentation by measuring reduction in hyphae formation in SLAD medium at 5 uM incubated for 3 to 5 days by stereomicroscopic analysis2022European journal of medicinal chemistry, Feb-15, Volume: 230Unraveling the anti-virulence potential and antifungal efficacy of 5-aminotetrazoles using the zebrafish model of disseminated candidiasis.
AID1889444Anti-virulence activity against Candida albicans SC5314 assessed as inhibition of fungal filamentation by measuring reduction in hyphae formation in RPMI medium at 5 uM incubated for 3 to 5 days by stereomicroscopic analysis2022European journal of medicinal chemistry, Feb-15, Volume: 230Unraveling the anti-virulence potential and antifungal efficacy of 5-aminotetrazoles using the zebrafish model of disseminated candidiasis.
AID1889402Antifungal activity against Candida albicans SC5314 assessed as inhibition of fungal growth at 250 uM incubated for 24 hrs by broth microdilution assay2022European journal of medicinal chemistry, Feb-15, Volume: 230Unraveling the anti-virulence potential and antifungal efficacy of 5-aminotetrazoles using the zebrafish model of disseminated candidiasis.
AID1889399Anti-infection activity against 53-75 RFP expressing cells of Candida albicans M137 in hind brain of zebra fish embryo disseminated candidiasis model assessed as reduction in embryo mortality at 2.5 to 10 uM treated at 1 hr post-infection and measured at 2022European journal of medicinal chemistry, Feb-15, Volume: 230Unraveling the anti-virulence potential and antifungal efficacy of 5-aminotetrazoles using the zebrafish model of disseminated candidiasis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.00)18.7374
1990's0 (0.00)18.2507
2000's7 (35.00)29.6817
2010's6 (30.00)24.3611
2020's6 (30.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.29 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.58 (4.65)
Search Engine Demand Index25.99 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (95.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]